3.41Open3.41Pre Close0 Volume10 Open Interest5.00Strike Price0.00Turnover0.00%IV-13.57%PremiumDec 20, 2024Expiry Date3.60Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.39Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Rani Therapeutics Stock Discussion
Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
No comment yet